| Michael Richard Rasmussen, MD | |
|
5121 S Cottonwood St, Murray, UT 84107-5701 | |
| (801) 507-7000 | |
| Not Available |
| Full Name | Michael Richard Rasmussen |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 15 Years |
| Location | 5121 S Cottonwood St, Murray, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336373851 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | A123505 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Park City Hospital | Park city, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mountain West Anesthesia Llc | 9032018502 | 248 |
News Archive
Diagnostic Devices, Inc. (DDI), the maker of Prodigy(R) blood glucose monitoring systems, and the leading provider of audible meters, is leading what could be a made-in-America revolution by doing the unthinkable and bringing manufacturing jobs home from China, according to experts in international trade.
A patient's very own skin cells may hold the key to new treatments and even cures for devastating neurological diseases. A generous $1 million donation from Mr. J. Sebastian van Berkom, and critical partnerships with Brain Canada, Laval University, Marigold Foundation and the FRQS-Réseau Parkinson Quebec are driving an innovative, iPSC (induced pluripotent stem cell) research platform that will transform research into Parkinson's and other neurological diseases.
Viruses that attack bacteria - bacteriophages - can be fussy: they only inject their genetic material into the bacteria that suit them. The fussiness of bacteriophages can be exploited in order to detect specific species of bacteria. Scientists from Warsaw have just demonstrated that bacteriophage-based biosensors will be much more efficient if prior to the deposition on the surface of the bacteriophage sensor their orientation is ordered in electric field.
Today, the U.S. Food and Drug Administration approved Nexviazyme (avalglucosidase alfa-ngpt) for intravenous infusion to treat patients 1 year of age and older with late-onset Pompe disease.
Eisenhower Health is the first hospital in Southern California to offer a new lung valve treatment for patients with severe COPD/emphysema.
› Verified 6 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629260880 PECOS PAC ID: 1850209420 Enrollment ID: O20031105000079 |
News Archive
Diagnostic Devices, Inc. (DDI), the maker of Prodigy(R) blood glucose monitoring systems, and the leading provider of audible meters, is leading what could be a made-in-America revolution by doing the unthinkable and bringing manufacturing jobs home from China, according to experts in international trade.
A patient's very own skin cells may hold the key to new treatments and even cures for devastating neurological diseases. A generous $1 million donation from Mr. J. Sebastian van Berkom, and critical partnerships with Brain Canada, Laval University, Marigold Foundation and the FRQS-Réseau Parkinson Quebec are driving an innovative, iPSC (induced pluripotent stem cell) research platform that will transform research into Parkinson's and other neurological diseases.
Viruses that attack bacteria - bacteriophages - can be fussy: they only inject their genetic material into the bacteria that suit them. The fussiness of bacteriophages can be exploited in order to detect specific species of bacteria. Scientists from Warsaw have just demonstrated that bacteriophage-based biosensors will be much more efficient if prior to the deposition on the surface of the bacteriophage sensor their orientation is ordered in electric field.
Today, the U.S. Food and Drug Administration approved Nexviazyme (avalglucosidase alfa-ngpt) for intravenous infusion to treat patients 1 year of age and older with late-onset Pompe disease.
Eisenhower Health is the first hospital in Southern California to offer a new lung valve treatment for patients with severe COPD/emphysema.
› Verified 6 days ago
| Entity Name | Mountain West Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558391763 PECOS PAC ID: 9032018502 Enrollment ID: O20040103000057 |
News Archive
Diagnostic Devices, Inc. (DDI), the maker of Prodigy(R) blood glucose monitoring systems, and the leading provider of audible meters, is leading what could be a made-in-America revolution by doing the unthinkable and bringing manufacturing jobs home from China, according to experts in international trade.
A patient's very own skin cells may hold the key to new treatments and even cures for devastating neurological diseases. A generous $1 million donation from Mr. J. Sebastian van Berkom, and critical partnerships with Brain Canada, Laval University, Marigold Foundation and the FRQS-Réseau Parkinson Quebec are driving an innovative, iPSC (induced pluripotent stem cell) research platform that will transform research into Parkinson's and other neurological diseases.
Viruses that attack bacteria - bacteriophages - can be fussy: they only inject their genetic material into the bacteria that suit them. The fussiness of bacteriophages can be exploited in order to detect specific species of bacteria. Scientists from Warsaw have just demonstrated that bacteriophage-based biosensors will be much more efficient if prior to the deposition on the surface of the bacteriophage sensor their orientation is ordered in electric field.
Today, the U.S. Food and Drug Administration approved Nexviazyme (avalglucosidase alfa-ngpt) for intravenous infusion to treat patients 1 year of age and older with late-onset Pompe disease.
Eisenhower Health is the first hospital in Southern California to offer a new lung valve treatment for patients with severe COPD/emphysema.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Richard Rasmussen, MD 3340 N Center St Ste 800, Lehi, UT 84043-7406 Ph: (801) 990-1911 | Michael Richard Rasmussen, MD 5121 S Cottonwood St, Murray, UT 84107-5701 Ph: (801) 507-7000 |
News Archive
Diagnostic Devices, Inc. (DDI), the maker of Prodigy(R) blood glucose monitoring systems, and the leading provider of audible meters, is leading what could be a made-in-America revolution by doing the unthinkable and bringing manufacturing jobs home from China, according to experts in international trade.
A patient's very own skin cells may hold the key to new treatments and even cures for devastating neurological diseases. A generous $1 million donation from Mr. J. Sebastian van Berkom, and critical partnerships with Brain Canada, Laval University, Marigold Foundation and the FRQS-Réseau Parkinson Quebec are driving an innovative, iPSC (induced pluripotent stem cell) research platform that will transform research into Parkinson's and other neurological diseases.
Viruses that attack bacteria - bacteriophages - can be fussy: they only inject their genetic material into the bacteria that suit them. The fussiness of bacteriophages can be exploited in order to detect specific species of bacteria. Scientists from Warsaw have just demonstrated that bacteriophage-based biosensors will be much more efficient if prior to the deposition on the surface of the bacteriophage sensor their orientation is ordered in electric field.
Today, the U.S. Food and Drug Administration approved Nexviazyme (avalglucosidase alfa-ngpt) for intravenous infusion to treat patients 1 year of age and older with late-onset Pompe disease.
Eisenhower Health is the first hospital in Southern California to offer a new lung valve treatment for patients with severe COPD/emphysema.
› Verified 6 days ago
Kendell Ryan Klingler, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 778 E Briarmeadow Ave, Murray, UT 84107 Phone: 208-390-7555 | |
Ethan K Fisher, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5121 S Cottonwood Street, Intermountain Medical Center, Murray, UT 84157 Phone: 801-507-5248 Fax: 801-733-5618 | |
Jason Hafer, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5121 S Cottonwood St, Murray, UT 84107 Phone: 801-455-8221 | |
Dr. Jayaprakash Moodalagiriappa, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 5121 S Cottonwood Street, Intermountain Medical Center, Murray, UT 84157 Phone: 801-507-5248 Fax: 801-432-2668 | |
Dr. Michael Marshall Beck, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5121 S Cottonwood St, Murray, UT 84107 Phone: 801-507-7000 Fax: 770-701-6675 | |
Mr. Joshua C Peterson, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5121 S Cottonwood Street, Murray, UT 84107 Phone: 801-507-7000 Fax: 770-701-6675 | |
Scott Nathan Hurst, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5121 S Cottonwood Street, Intermountain Medical Center, Murray, UT 84157 Phone: 801-507-5248 Fax: 801-733-5618 |